RARE ALERT: Motif Bio said to have kicked off $3 million equity fundraising - sources
Motif Bio, a clinic stage biopharmaceutical company, is tapping investors for up to $3 million.
People claiming to be familiar with the situation said Motif Bio is looking to raise the fresh capital at a 25pc discount to last Friday's opening price.
The proceeds from the equtiy fundraising will be used as working capital, said people claiming to be familiar with the matter...
Register
Register for free to see rest of this article and all public articles from Betaville
Login / RegisterDate: Monday, 25 March 2019, 6:38 am